Clinical trial
Efficacy of Novel Drug-combinations for Relief of Psoriasis (ENDURE)
NCT02394301 is registered in ClinicalTrials.gov with Medimix Specialty Pharmacy, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Novel Drug-combinations for Relief of Psoriasis (ENDURE)
- Lead sponsor
- Medimix Specialty Pharmacy, LLC
- Phase
- Observational
- Overall status
- Suspended
- Start date
- February 28, 2015
- Completion date
- December 31, 2015
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.